Moderna shares plunge after cancer vaccine data leaks — despite positive results

Business

Moderna released full data on its closely watched cancer vaccine developed with Merck.

Read the original report.

Articles You May Like

Top Wall Street analysts are bullish on the growth potential of these 3 stocks
Bushfires are costing Australia $6 billion a year, and a strong El Niño summer is coming
‘Dead money’ for a decade: Why this hedge fund approach may deliver an advantage over bonds
College was supposed to be ‘good debt.’ For many borrowers, it isn’t paying off
Is It Time To Rebalance Your Retirement Income Portfolio?

Leave a Reply

Your email address will not be published. Required fields are marked *